Physician profile
Heather Lynn Chaney
NPI 1528796836
$1,022.57
in general payments reported to CMS, 2019-2025
19 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $206 · 2024: $444 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943 · Education: $80.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $942.57 |
| Education | $80.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $132.83 | 2023-2025 | Gemtesa, Orgovyx, Myfembree |
| Abbvie INC. | $110.67 | 2023-2025 | |
| Emd Serono, INC. | $104.67 | 2024 | |
| Seagen INC. | $80.00 | 2025 | |
| Teleflex LLC | $79.67 | 2024 | Urolift |
| Urogen Pharma, INC. | $73.82 | 2023-2025 | Jelmyto |
| Antares Pharma, INC. | $68.24 | 2024-2025 | Xyosted |
| Convatec INC. | $65.82 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.13 | 2023-2024 | |
| Immunitybio, INC. | $38.68 | 2024 | |
| Janssen Biotech, INC. | $35.87 | 2024-2025 | Erleada |
| Tolmar, INC. | $29.18 | 2024-2025 | Jatenzo, Eligard |
| Edap Technomed INC | $27.99 | 2025 | |
| Boston Scientific Corporation | $24.49 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $24.13 | 2024 | Personal Catheter Intermittent Catheter |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $23.44 | 2023 | Axonics |
| Progenics Pharmaceuticals, INC. | $21.00 | 2023 | Pylarify |
| Merck Sharp & Dohme LLC | $19.57 | 2023 | Keytruda, Lynparza |
| Karyopharm Therapeutics INC. | $17.37 | 2023 | Xpovio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Chaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.